Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 5, 2005, Pages 1385-1388

  Shi, Zhen Dan ^a   Karki, Rajeshri G ^a   Oishi, Shinya ^a   Worthy, Karen M ^b   Bindu, Lakshman K ^b   Dharmawardana, Pathirage G ^a   Nicklaus, Marc C ^a   Bottaro, Donald P ^a   Fisher, Robert J ^b   Burke Jr , Terrence R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROBENZOXADIAZOLE; PEPTIDE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG ACTIVITY; DRUG DESIGN; FLUORESCENCE;

EID: 13944263892     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.01.017     Document Type: Article

References (28)

1. R.J. Daly, M.D. Binder, and R.L. Sutherland Oncogene 9 1994 2723
2. C. Garbay, W.Q. Liu, M. Vidal, and B.P. Rogues Biochem. Pharmacol. 60 2000 1165
3. D. Dankort, B. Maslikowski, N. Warner, N. Kanno, H. Kim, Z.X. Wang, M.F. Moran, R.G. Oshima, R.D. Cardiff, and W.J. Muller Mol. Cell. Biol. 21 2001 1540
4. C. Saucier, V. Papavasiliou, A. Palazzo, M.A. Naujokas, R. Kremer, and M. Park Oncogene 21 2002 1800
5. S. Osada, and S. Saji Curr. Med. Chem., Anti-Cancer Agent 3 2003 119
6. S.M. Feller, G. Tuchscherer, and J. Voss Leukemia Lymphoma 44 2003 411
7. P. Furet, B. Gay, G. Caravatti, C. Garcia-Echeverria, J. Rahuel, J. Schoepfer, and H. Fretz J. Med. Chem. 41 1998 3442
8. Z.J. Yao, C.R. King, T. Cao, J. Kelley, G.W.A. Milne, J.H. Voigt, and T.R. Burke J. Med. Chem. 42 1999 25
9. C.-Q. Wei, B. Li, R. Guo, D. Yang, and T.R. Burke Jr. Bioorg. Med. Chem. Lett. 12 2002 2781
10. Numerous reports have appeared detailing the use of fluorescent ligands to study protein interactions within cellular contexts. For recent examples, see: I. Berque-Bestel, J.-L. Soulier, M. Giner, L. Rivail, M. Langlois, and S. Sicsic J. Med. Chem. 46 2003 2606
11. P. Ettmayer, A. Billich, T. Baumruker, D. Mechtcheriakova, H. Schmid, and P. Nussbaumer Bioorg. Med. Chem. Lett. 14 2004 1555
12. Nomenclature as suggested by Eck Nature 362 1994 87
13. J. Schoepfer, H. Fretz, B. Gay, P. Furet, C. Garcia-Echeverria, N. End, and G. Caravatti Bioorg. Med. Chem. Lett. 9 1999 221
14. A. Cotte, B. Bader, J. Kuhlmann, and H. Waldmann Chem. Eur. J. 5 1999 922
15. +]
16. +]
17. +]
18. +]
19. +]
20. 6-DMSO) δ 9.38 (t, 1H, J = 6.0 Hz), 8.51 (d, 1H, J = 9.0 Hz), 8.29 (s, 1H), 7.70-7.66 (m, 2H), 7.35 (s, 1H), 7.16-7.09 (m, 4H), 6.89 (s, 1H), 6.44 (d, 1H, J = 9.0 Hz), 4.33 (m, 1H), 3.58-3.52 (m, 2H), 3.41-3.37 (m, 2H), 3.10 (m, 1H), 2.97 (dd, 1H, J = 5.0 Hz & 13.3 Hz), 2.89 (d, 2H, J = 21.3 Hz), 2.62 (dd, 1H, J = 6.6 Hz & 15.6 Hz), 2.50 (dd, 1H, J = 5.1 Hz & 15.5 Hz), 2.43 (dd, 1H, J = 10.4 Hz & 16.9 Hz), 2.32 (dd, 1H, J = 9.9 Hz & 13.1 Hz), 1.98 (dd, 1H, J = 4.1 Hz & 16.8 Hz), 1.84-1.07 (m, 10H). FABMS (+Ve) m/z 745 [M-H]
21. 50 values, and statistically significant differences were determined using GraphPad InStat Software analysis of two or more independent ELISA experiments
22. Oishi, S.; Karki, R. G.; Kang, S.-U.; Wang, X.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R., Jr. J. Med. Chem., in press
23. F. Mohamadi, N.G.J. Richards, W.C. Guida, R. Liskamp, M. Lipton, C. Caufield, G. Chang, T. Hendrickson, and W.C. Still J. Comput. Chem. 11 1990 440
24. P. Nioche, W.Q. Liu, I. Broutin, F. Charbonnier, M.T. Latreille, M. Vidal, B. Roques, C. Garbay, and A. Ducruix J. Mol. Biol. 315 2002 1167
25. T.A. Halgren J. Comput. Chem. 17 1996 490
26. D. Qiu, P.S. Shenkin, F.P. Hollinger, and W.C. Still J. Phys. Chem. A 101 1997 3005
27. Computational results were obtained using the software program Insight II by Accelrys Inc., San Diego, CA (http://www.accelrys.com/)
28. Frisch, M. J.; et al. Gaussian 03, Revision B.04 2003